well
Field Reports
FDA approves GSK’s bepirovirsen for chronic hepatitis B
On October 20, the FDA cleared bepirovirsen, marketed as Hibsago, for use in adults battling chronic hepatitis B virus (HBV). This drug,…
On October 20, the FDA cleared bepirovirsen, marketed as Hibsago, for use in adults battling chronic hepatitis B virus (HBV). This drug,…